Quotulatiousness

June 21, 2013

The healing powers of silver

Filed under: Health, Science — Tags: , , , — Nicholas @ 09:01

In The Economist, some new ideas about silver:

Silver has long been known as more than bling. In the fifth century BC Hippocrates noted its ability to preserve food and water. In the late 19th century silver-nitrate eye drops were administered to newborns to prevent conjunctivitis (though this remedy has since been replaced with an antibiotic). Today silver is routinely found in wound dressings and catheters to treat or prevent infections. Yet, despite its widespread use, the source of silver’s antibacterial properties has remained shrouded in mystery.

Now Jose Morones-Ramirez, from Boston University, and colleagues think they may have cracked it. As they report in Science Translational Medicine, silver fights bacteria in a number of ways.

First, silver ions (as atoms stripped of some of their electrons are known) help, through a process known as the Fenton reaction, to convert hydrogen peroxide into molecules called hydroxyl radicals. Radicals are unstable and readily react with cellular components, damaging them. Indeed, an excess is thought to contribute to ageing-related illnesses in humans. However, the researchers found, concentrations of silver ions low enough to leave human cells unscathed nonetheless appear to wreak havoc on bacterial ones.

Using a dye that glows in the presence of hydroxyl radical, Dr Morones-Ramirez treated the bacterium Escherichia coli with silver nitrate (a source of silver ions). The E. coli glowed, and then promptly bit the dust. But when the bacteria were first bathed in a chemical which mops up the hydroxyl radicals, they survived. This points to silver’s effect on the production of hydroxide radicals as the explanation.

June 19, 2013

Examining Vermouth’s claim to being the “oldest wine in the world”

Filed under: Greece, Health, History, Italy, Middle East, Wine — Tags: , — Nicholas @ 08:13

History Today linked to an article in their archives from 1975 from Pamela Vandyke Price discussing the ancient provenance of Vermouth:

When the great vermouth establishments refer to their product as ‘the oldest form of wine in the world’, they are not exaggerating. If we could travel in time, we might find many of the wines praised in antiquity to be harsh, sour and coarse to our palates, but the ‘aromatized wine’ that we know as vermouth would then have existed and, even if we drank it for medicinal or preventive reasons rather than for enjoyment, we could recognise it and relate it to the vermouths of today.

Vermouth can be, and often is, made wherever wine is made. The ancient Egyptians used both wine and beer, plus juniper, frankincense, celery, lotus leaves and honey, in the treatment of certain ailments; and it is by a method of infusion, maceration, distillation, or two or all three of these processes that, essentially, vermouth is made today. In Book IV of the Odyssey, Helen throws a drug given to her by an Egyptian lady into the bowl in which the wine is to be mixed and diluted before dinner; this ‘had the power of robbing grief and anger of their sting and banishing all painful memories’ — an efficacious aperitif, assuring good digestion. At the end of the third millennium B.C. what is perhaps the first written doctor’s prescription is recorded in cuneiform script on a tablet from the Sumerian city of Nippur — a physician notes that certain powders should be infused with a type of wine.

[. . .]

Other families in the drink business were quick to see the possibilities for vermouth, setting up in Turin, Marseilles and Sete (again in proximity to mountain herbs and a quantity of wine), and in Chambray. Many of them are still family concerns, even though they are great empires of the drink business. Martini & Rossi, who were founded about 1840, replaced a much older concern making vermouths and liqueurs at Pessione, near Turin (the head of that firm was the grandfather of Giovanni Angelli, founder of Fiat); the superb museum now established alongside the Pessione installations is a necessary detour for anyone interested in the history of wine from the earliest times.

The Cinzano family began in the drink business in the sixteenth century, and in 1757 the brothers Carlo Stefano and Giovanni Giacomo were invested as Master Distillers in Turin; today their business is gigantic, including, among other things, the Florio concern at Marsala, (itself including the former cantinas of Ingham and Woodhouse). Louis Noilly, in business at the beginning of the nineteenth century in Lyons, set up in the vermouth trade with his son-in-law, Claudius Prat and they enjoyed so much success that by 1843 they moved their headquarters to Marseilles. Madame Josephine Prat, who ran the business after the deaths of the two founders, was succeeded by her two children; and her granddaughter, Vicomtesse Vigier, who entered the firm before 1939, directed it until 1970 when she died, over a hundred years old.

It seems a little odd that, with so many modifications of wine-making and changes in the tastes of drinkers, aromatized wine should still be in demand. But, in fact, it is increasingly so. Whenever people order a straight vermouth they are ordering the oldest wine in the world.

June 12, 2013

Changing the FDA to meet the new needs of personalized medicine

Filed under: Health, Science — Tags: , , , , — Nicholas @ 08:31

At Marginal Revolution, Alex Tabarrok links to a new paper by Peter Huber:

In a brilliant new paper (pdf) (html) Peter Huber draws upon molecular biology, network analysis and Bayesian statistics to make some very important recommendations about FDA policy.

[. . .]

The current regime was built during a time of pervasive ignorance when the best we could do was throw a drug and a placebo against a randomized population and then count noses. Randomized controlled trials are critical, of course, but in a world of limited resources they fail when confronted by the curse of dimensionality. Patients are heterogeneous and so are diseases. Each patient is a unique, dynamic system and at the molecular level diseases are heterogeneous even when symptoms are not. In just the last few years we have expanded breast cancer into first four and now ten different types of cancer and the subdivision is likely to continue as knowledge expands. Match heterogeneous patients against heterogeneous diseases and the result is a high dimension system that cannot be well navigated with expensive, randomized controlled trials. As a result, the FDA ends up throwing out many drugs that could do good:

    Given what we now know about the biochemical complexity and diversity of the environments in which drugs operate, the unresolved question at the end of many failed clinical trials is whether it was the drug that failed or the FDA-approved script. It’s all too easy for a bad script to make a good drug look awful. The disease, as clinically defined, is, in fact, a cluster of many distinct diseases: a coalition of nine biochemical minorities, each with a slightly different form of the disease, vetoes the drug that would help the tenth. Or a biochemical majority vetoes the drug that would help a minority. Or the good drug or cocktail fails because the disease’s biochemistry changes quickly but at different rates in different patients, and to remain effective, treatments have to be changed in tandem; but the clinical trial is set to continue for some fixed period that doesn’t align with the dynamics of the disease in enough patients

    Or side effects in a biochemical minority veto a drug or cocktail that works well for the majority. Some cocktail cures that we need may well be composed of drugs that can’t deliver any useful clinical effects until combined in complex ways. Getting that kind of medicine through today’s FDA would be, for all practical purposes, impossible.

The alternative to the FDA process is large collections of data on patient biomarkers, diseases and symptoms all evaluated on the fly by Bayesian engines that improve over time as more data is gathered. The problem is that the FDA is still locked in an old mindset when it refuses to permit any drugs that are not “safe and effective” despite the fact that these terms can only be defined for a large population by doing violence to heterogeneity. Safe and effective, moreover, makes sense only when physicians are assumed to be following simple, A to B, drug to disease, prescribing rules and not when they are targeting treatments based on deep, contextual knowledge that is continually evolving

March 29, 2013

Demonizing smokers hasn’t forced them to quit … let’s start sending them to psychiatric care instead

Filed under: Britain, Health, Media — Tags: , , , , , — Nicholas @ 09:53

When the all the persuasion, “nudging”, shaming, harassment, and legal shenanigans haven’t worked, try taking a leaf out of the old Soviet Union playbook for dealing with dissidents:

Smoking may be a sign of psychiatric illness, experts say. Doctors should routinely consider referring people who smoke to mental health services, in case they need treatment, they add.

The controversial recommendation from the British Lung Foundation, a charity, comes in response to a major report, Smoking and Mental Health, published this week by the Royal College of Physicians and the Royal College of Psychiatrists with the Faculty of Public Health. It says that almost one in three cigarettes smoked in Britain today is smoked by someone with a mental disorder. When people with drug and alcohol problems are included the proportion is even higher.

The reason is that smoking rates have more than halved over the past 50 years, but the decline has not happened equally in all parts of society.

“Smoking is increasingly becoming the domain of the most disadvantaged: the poor, homeless, imprisoned and those with mental disorder. This is a damning indictment of UK public health policy and clinical service provision,” the report says.

March 14, 2013

The scare stories about increasing antibiotic resistance

Filed under: Bureaucracy, Business, Health, Science — Tags: , , , , — Nicholas @ 09:36

In sp!ked, Robin Walsh debunks some of the scare factor from recent reports about antibiotic resistant diseases and the looming pandemic:

The UK’s chief medical officer (CMO), Professor Dame Sally Davies, made a splash in the media this week with her warning that antibiotic resistance is the new climate change. There is a ‘catastrophic threat’ of ‘untreatable’ diseases, she said, which promise to return us to a ‘nineteenth century’ state of affairs. The CMO has form: she warned the House of Commons health select committee about the same problem in similarly stringent terms back in January — a case not so much of apocalypse now, as apocalypse again.

As with all such stories, reading the actual CMO’s report leavens some of the hysterical excesses of the press, which were stoked up by the CMO’s excitable media appearances. Setting out the epidemiology of infectious diseases in the UK, the report highlights that while some drug-resistant infections, such as the well-known Clostridium difficile (C diff) and MRSA, are becoming less widespread, there is an increasing occurence of harder to treat multi-drug resistant bacterial infections, which, although still only in the hundreds of cases per year, are on the rise. The report states that only five antibiotics to fight such infections are currently in phase II or III trials, so the cupboard seems worryingly bare of new, necessary drugs.

So if we’re running short on drugs, how can we make more? A sensible article in the British Medical Journal from 2010 clearly set out the challenges facing the development of new antibiotics. Firstly, there are many regulatory hurdles that make running clinical trials in this area difficult. More importantly, there is a major financial disincentive for drug companies to develop antibiotics. Currently, drugs which are profitable are those for chronic conditions that are prescribed lifelong: painkillers for arthritis, diabetes drugs, and the like. A drug that you take once to cure you is unprofitable; doubly so if it is likely to be husbanded to prevent resistance developing until the patent runs out. A change in government payments to incentivise new antibiotics, like that which already applies to so-called ‘orphan’ drugs for rare diseases, would be an easy and rational step towards producing more drugs that meet our needs.

February 6, 2013

Old and busted: organ transplants. New hotness: 3D organ printing

Filed under: Health, Science, Technology — Tags: , , , , — Nicholas @ 00:03

Matt Peckham on the very near future of organ replacement technology:

Say you need a new trachea, a part of the body we’ve already managed to replicate using stem cells and successfully transplant to a human with late-stage tracheal cancer (I’m not making that up or exaggerating). With a 3D printer and a bunch of stem cell-saturated bio-ink, you might be able to just print that trachea on demand thanks to a new technique that lets you pass human embryonic stem cells (hESCs) through a printer nozzle without destroying them.

A team of researchers from Scotland announced Monday that they’d finally managed to get an inkjet-style printer to craft an organic 3D object. Not an actual organ (well, not yet), but these scientists claim they’ve been able to clear a crucial hurdle: getting hESCs, prized for their ability to become cells of any tissue type, to survive the printing process.

The solution involved rejiggering the way the inkjet-style 3D printer worked, specifically the printing valve, which had to be tweaked to ever-so-gently deposit blobs of hESCs in programmable patterns without compromising the viability and functionality of the cells themselves. The researchers figured out how to do this using two types of bio-inks as well as allow for independent control of the amount in each droplet (with considerable control granularity — down to less than five cells per droplet). The results of the experiment were just published in the bio-science print and online journal Biofabrication.

September 28, 2012

The future of electronics might be biodegradable

Filed under: Health, Technology — Tags: , , — Nicholas @ 08:14

Brid-Aine Parnell at The Register, talking about specialized electronic development:

When it comes to electronics, boffins are usually going one way — how to make them smaller, faster and longer lasting, but a few researchers are going against the tide — looking for electronics that can last just a moment and then disappear.

At the University of Illinois, with help from Tufts and Northwestern Universities, scientists have come up with biodegradable electronics that can do their job and then dissolve. Apart from reducing the amount of consumer electronics in landfills, the disappearing gizmos could also work as medical implants, before dissolving in bodily fluids, as environmental monitors or any other device that needs to disappear.

“From the earliest days of the electronics industry, a key design goal has been to build devices that last forever — with completely stable performance,” Illinois professor of engineering and project leader John Rogers said.

“But if you think about the opposite possibility — devices that are engineered to physically disappear in a controlled and programmed manner — then other, completely different kinds of application opportunities open up.”

September 11, 2012

More evidence that a bit of dirt can be a healthy thing for kids

Filed under: Health, Media, Science — Tags: , , , — Nicholas @ 00:02

Matt Ridley reviews a new book by Moises Velasquez-Manoff:

In a remarkable new book, “An Epidemic of Absence,” Moises Velasquez-Manoff draws together hundreds of such studies to craft a powerful narrative carrying a fascinating argument. Infection with parasites prevents or ameliorates many diseases of inflammation. The author briefly cured his own hay fever and eczema by infecting himself with hookworms-before concluding that the price in terms of diarrhea and headaches was too high.

I’ve touched on the “hygiene hypothesis” in these pages before. In its cartoon form the argument-that in a clean world our immune system gets bored and turns on itself or on harmless pollen-isn’t very convincing. But Mr. Velasquez-Manoff makes a far subtler, more persuasive case. Parasites have evolved to damp our immune responses so that they can stay in our bodies. Our immune system evolved to expect parasites to damp it. So in a world with no parasites, it behaves like a person leaning into the wind when it drops: The system falls over.

Moreover, just as brains outsource much of their development to the outside world-the visual system is refined by visual input, the language system can only develop in a language-using society — so the immune system seems to have happily outsourced much of its regulation to friendly microbes. Without them, the immune system becomes unbalanced.

[. . .]

One of Mr. Velasquez-Manoff’s most surprising chapters is on autism, a disorder that almost exactly parallels asthma in its recent rise among affluent, urban, mainly male, disproportionately firstborn people. Better diagnosis explains perhaps half the rise, but the brains of people with autism are often inflamed, and there’s anecdotal evidence that infection with worms or viruses can tame autistic symptoms, at least temporarily.

September 5, 2012

Our conflicted feelings about athletes “juicing”

Filed under: Football, Health, Science, Sports — Tags: — Nicholas @ 08:13

In a sport that most people don’t care about unless a local player is doing well internationally (competitive cycling, for example), a scandal over performance enhancing drugs is a good opportunity to make noises about the “purity of the sport” and demand major sanctions against those who cheat. However, as Jim Souhan points out at the Star Tribune, we’re rather good at turning a blind eye to the same thing in sports we care more about:

The advent of the NFL season will provide a respite from sports riddled with performance-enhancing drugs, such as baseball and cycling.

If you can read that sentence without laughing, you are one naive fan.

We know many baseball players cheated in the ’90s and early 2000s, and we know some cheat today. For every Melky Cabrera who gets caught there must be dozens, if not hundreds, who are smart enough to avoid testing positive in a system that is easy to beat.

We know cyclists cheat. The evidence is overwhelming. When Lance Armstrong pretended to take a principled stand by abandoning his legal fight to defend himself, he was avoiding facing public testimony by a squadron of former teammates. Now another former teammate, Tyler Hamilton, has written a book in which he details his own, and Armstrong’s, cheating, and other former Armstrong associates are speaking openly about his PED use.

[. . .]

If Armstrong could avoid testing positive for PEDs while winning the Tour de France seven times, what does that tell us about the National Football League, a sport filled with the biggest, strongest, fastest and most explosive athletes in our society?

That’s right: The NFL must be stuffed with performance enhancers.

The difference is that we don’t care.

August 28, 2012

Rehabilitating Florence Nightingale’s reputation

Filed under: Britain, Health, History, Military, Russia — Tags: , , , , — Nicholas @ 08:31

History Today has a defence of the much-maligned Florence Nightingale:

Jamaican-born Mary Seacole (1805-81), voted top of the list of the 2004 ‘100 Great Black Britons’ poll, is now slated to replace Florence Nightingale (1820-1910) as the true ‘heroine’ of the Crimean War. She is to be honoured as no less than the ‘Pioneer Nurse’ with a massive statue to be erected at St Thomas’ Hospital in London. This in spite of the strong links between Nightingale and the hospital, her base for over 40 years. It was there she established the first secular school for nurses in 1860 with funds raised in her name for her work in the Crimean War during the conflict of 1854-56. The Nightingale School operated for over a century from the hospital, whose redesign in the 1860s Nightingale also influenced.

[. . .]

The campaign promoting Seacole over Nightingale builds on 30 years of books, articles and films denigrating the latter. While she always had detractors, the serious assault on Nightingale’s reputation can be dated to 1982, with the publication of the Australian historian F.B. Smith’s Florence Nightingale: Reputation and Power (Croom Helm, 1982). The next major hit came in 1998 with Florence Nightingale: Avenging Angel (Constable, 1998) by a retired management consultant Hugh Small, which argues that Nightingale was actually responsible for the high death rates of the Crimean War and had a nervous breakdown as a result when she supposedly recognised this. Neither claim is supported by any serious documentation. Social media goes even further: see Facebook ‘Florence Nightingale was a Murdering Bitch’, later renamed ‘Florence Nightingale: The World’s Worst Nurse’, where she is described as a ‘deluded power hungry bitch’, who ‘looks like an uptight bitch’, so that ‘the day she died’ was ‘the best thing that ever happened to the field of nursing’.

[. . .]

The French were the instigators of the Crimean War, sent more troops and were better prepared than the British. Their death rates were lower in the first year. But the British government learned from the commissions it sent out and made enormous changes. British death rates fell dramatically, from 23 per cent in the first winter to 2.5 per cent in the second — no greater than deaths among soldiers in peacetime barracks in London, as Nightingale proudly showed in a chart. In contrast, the French (lower) 11 per cent death rate in the first winter, rose to 20 per cent in the second winter. Since the French were late in publishing their statistics, neither Nightingale nor the royal commission could use them for comparison. However French doctors themselves credited the British reforms for their superior performance. Once they were properly cleansed and functioning Nightingale was proud of the Crimean hospitals. In her own charts she separated the two periods, before and after the sanitary and supply commissions, to emphasise the crucial role they played in reducing mortality.

Her analysis of what went wrong was widely accepted and led to major changes to health care in the British Army. The ‘Nightingale Fund’ raised in her honour for that work paid for the training school at St Thomas’, which led to raising nursing to the level of a profession throughout much of the world. Her experience of the war, and her reputation and research as a result of it, grounded all the social and public health work she did for the rest of her life. Her vision for health reform included bold statements, such as the belief that the poor should receive as good quality hospital care as private patients and warnings as to the dangers of hospital acquired infections. Nightingale, in short, is no mere historical figure. Her lamp should not be retired but shone brightly onto the hospital and health care problems of today.

August 25, 2012

Yet another factor in obesity

Filed under: Food, Health, Science — Tags: , — Nicholas @ 00:09

“I want to say one word to you. Just one word.” Antibiotics.

We aren’t single individuals, but colonies of trillions. Our bodies, and our guts in particular, are home to vast swarms of bacteria and other microbes. This “microbiota” helps us to harvest energy from our food by breaking down the complex molecules that our own cells cannot cope with. They build vitamins that we cannot manufacture. They ‘talk to’ our immune system to ensure that it develops correctly, and they prevent invasions from other more harmful microbes. They’re our partners in life.

What happens when we kill them?

Farmers have been doing that experiment in animals for more than 50 years. By feeding low doses of antibiotics to healthy farm animals, they’ve found that they could fatten up their livestock by as much as 15 percent. You can put the antibiotics in their feed or in their water. You can give the drugs to cows, sheep, pigs or chickens. You can try penicillins, or tetracyclines, or many other classes of antibiotics. The effect is the same: more weight.

It seems reasonable to assume that this effect is also true for humans. And we dose ourselves with antibiotics far more than we should (often for things that do not respond to antibiotics at all … a twist on the placebo effect). In addition, many of the animals we raise for meat are regularly dosed with antibiotics.

For now, two things are clear. First, antibiotics have done a huge amount of good in treating bacterial infections and if we’re even talking about reducing their use, it’s because we have the luxury of health that they have provided. Second, they are clearly overused: prescribed for illnesses that they have no power over, and used to fatten livestock that aren’t sick. Currently, on average, every American child gets a course of antibiotics ever year.

The overuse of antibiotics has fuelled the rise of antibiotic-resistant bacteria, but their impact on our beneficial bacteria could be equally detrimental. Blaser has been vociferously banging on this drum for years. As he wrote in a comment piece for Nature, “Antibiotics kill the bacteria we do want, as well as those we don’t… Overuse of antibiotics could be fuelling the dramatic increase in conditions such as obesity, type 1 diabetes, inflammatory bowel disease, allergies and asthma… We must make use of the available technology to protect and study our bacterial benefactors before it is too late.”

June 8, 2012

Allergy season strikes

Filed under: Health, Randomness — Tags: — Nicholas @ 07:43

I’ve had fall and spring allergy issues since I was a teenager. They’re pretty predictable in symptoms: dry, itchy eyes and full sinuses followed by sneezing and/or coughing (depending on which direction the sinus overflow headed). Over the last several years, the intensity of the allergy attacks has steadily declined, which has been great. This week, however, I got the worst symptoms I’ve had in at least a decade and it came on with little warning.

I tried to tough it out for the first couple of days, but as I really wanted to be awake and de-symptomized for the GW2 Beta Weekend Event kicking off later today, I figured I’d better take some allergy medicine. It turns out the only package of Claritin I had is past its use-by date. The unopened package expired in October.

Of 2009

I guess I really have been doing well in the allergy line recently.

March 10, 2012

Some diseases may be caused by “endogenous” retrovirii

Filed under: Health, Science — Tags: , , , , — Nicholas @ 12:17

Matt Ridley on some recent discoveries in genetics and medicine that may help to explain certain diseases like multiple sclerosis:

The virus implicated in multiple sclerosis is called HERV-Fc1, a bizarre beast called an “endogenous” retrovirus. What this means is that its genes are part of the human genome. For millions of years, they have been integrated into our own DNA and passed on by normal heredity. It was one of the shocks of genomic science to find that the human genome contains more retroviral than “human” genes: some 5% to 8% of the entire genome.

Normally, the genes of endogenous retroviruses remain dormant, but — a bit like a computer virus that springs into action on a trigger — something wakes them up sometimes, and actual viruses are made from them, which then infect other cells in the body. The Danish scientists suggest that this is what happens in multiple sclerosis. Bjørn Nexø of Aarhus University writes that “retroviral infections often develop into running battles between the immune system and virus, with the virus mutating repeatedly to avoid the immune system, and the immune system repeatedly catching up. One can see the episodic nature of multiple sclerosis as such a running battle.”

The possibility that you can inherit the genes of a virus blurs the distinction between a genetic and an infectious disease. The HERV-Fc1 genes lie on the X chromosome. Since women have twice as many X chromosomes as men, this might explain why some forms of MS are more common in women. Dr. Nexø concludes hopefully: “The finding that a disease is caused by an infectious agent is an encouraging one. These are the diseases which we know best how to treat.

The research also appears to show a link between cat ownership and schizophrenia:

Human beings can also catch toxoplasma from cats, and it’s known to affect behavior: altering personalities, slowing reaction times and increasing the risk of car accidents. More than 20 studies have now found an association between schizophrenia and toxoplasma. Schizophrenia is more common among those who had pet cats in their childhood homes (but not in those who had pet dogs).

Indeed, some scientists think that schizophrenia only became common, around 1870, when keeping cats as indoor pets became fashionable. The parasite has genes for dopamine, a neurochemical found in excess in schizophrenics.

January 15, 2012

As you’d expect, healthcare costs are not evenly distributed

Filed under: Economics, Health, USA — Tags: , , , — Nicholas @ 12:20

Jordan Weissmann in The Atlantic:

When it comes to America’s spiraling health care costs, the country’s problems begin with the 5%. In 2008 and 2009, 5% of Americans were responsible for nearly half of the country’s medical spending.

Of course, health care has its own 1% crisis. In 2009, the top 1% of patients accounted for 21.8% of expenditures.

The figures are from a new study by the Department of Health and Human Services, which examined how different U.S. demographics contributed to medical costs. It looked at the $1.26 trillion spent by civilian, non-institutionalized Americans each year on health care.

The top 5% of spenders paid an annual average of $35,829 in doctors’ bills. By comparison, the bottom half paid an average $232 and made up about 3% of total costs.

January 11, 2012

Computers as doctors

Filed under: Health, Technology — Tags: , — Nicholas @ 12:02

An interesting post from Alex Tabarrok at Marginal Revolution:

In 2004 I wrote In Praise of Impersonal Medicine arguing:

    I have nothing against my physician but I would prefer to be diagnosed by a computer. A typical physician spends most of the day playing twenty questions. Where does it hurt? Do you have a cough? How high is the patient’s blood pressure? But an expert system can play twenty questions better than most people. An expert system can use the best knowledge in the field, it can stay current with the journals, and it never forgets.

and in 2006 I noted:

    The practice of modern medicine is surprisingly primitive … My credit card company knows far more about my shopping history than my physician knows about my medical history.

I now believe that we are on the cusp of major changes to medicine. The thousand dollar genome sequence is less than a year away, Ford has just developed a car seat that can monitor your health, many people are already using wrist monitors to measure heart and sleep patterns. All of this data will soon be combined with massive databases to offer predictive and prescriptive health diagnosis.

But my favourite part of the posting was this comment from Joseph Huntington:

Stay clear of Doctors. I am a lifelong physician. Cardiologist, Head Surgeon, UCLA for 17 years. Medicine today is riskier than any casino. I left the zoo when it became a Federal Collection Center for data that will likely be used in population selection. If you’re a model or athlete, you have nothing to fear. If you’re sub-average, or over age 35 … just sleep well, drink water, walk, breathe deeply, eat mostly fresh things, laugh, love, work honorably and again, stay away from guys like me.

« Newer PostsOlder Posts »

Powered by WordPress